Related Experiment Video

Updated: Aug 16, 2026

Guidelines for Elective Pediatric Fiberoptic Intubation
11:19

Guidelines for Elective Pediatric Fiberoptic Intubation

Published on: January 17, 2011

Strong opioids in pediatric palliative medicine

Richard D W Hain1, Angela Miser, Mary Devins

  • 1Department of Child Health, University of Wales College of Medicine, Cardiff, Wales, UK. HainRD@Cardiff.ac.uk

Paediatric Drugs
|March 22, 2005
PubMed

Insights

Opioids are now essential for managing moderate-to-severe pain in children receiving palliative care. Pediatric palliative care requires confident opioid use, despite unique pharmacokinetic challenges in children.

Area of Science:

  • Pediatric Palliative Care
  • Pain Management
  • Pharmacology

Background:

  • Pain management in pediatric palliative care differs from adult care and other childhood pain types.
  • Opioids, once considered unsuitable for children, are now the primary analgesia for moderate-to-severe pain in life-limiting conditions.
  • Limited specific data exists for pediatric opioid use, necessitating extrapolation from adult palliative medicine.

Purpose of the Study:

  • To highlight the unique challenges and essential considerations for opioid use in pediatric palliative care.
  • To emphasize the importance of confident and rational opioid administration by pediatricians.
  • To underscore the role of World Health Organization (WHO) guidelines in managing pain in children with life-limiting conditions.

Main Methods:

  • Review of existing literature on pediatric palliative pain management.
  • Extrapolation of adult palliative medicine data for opioid use in children.
  • Consideration of early research on pediatric opioid pharmacokinetics.

Main Results:

  • Opioids are the mainstay for moderate-to-severe pain in pediatric palliative care for both malignant and non-malignant conditions.
  • Early research suggests potential pharmacokinetic differences in children, such as faster morphine clearance compared to adults.
  • Pediatric palliative care presents unique challenges in opioid management.

Conclusions:

  • Confident and rational use of opioids, guided by WHO principles, is crucial for effective pain management in pediatric palliative care.
  • Understanding and addressing the unique pharmacokinetic profiles of opioids in children is essential.
  • Opioid analgesia is vital for improving the quality of life for children with life-limiting conditions.

More Related Videos

Assessment of Morphine-induced Hyperalgesia and Analgesic Tolerance in Mice Using Thermal and Mechanical Nociceptive Modalities07:23

Assessment of Morphine-induced Hyperalgesia and Analgesic Tolerance in Mice Using Thermal and Mechanical Nociceptive Modalities

Published on: July 29, 2014

Combining Laser Capture Microdissection and Microfluidic qPCR to Analyze Transcriptional Profiles of Single Cells: A Systems Biology Approach to Opioid Dependence09:54

Combining Laser Capture Microdissection and Microfluidic qPCR to Analyze Transcriptional Profiles of Single Cells: A Systems Biology Approach to Opioid Dependence

Published on: March 8, 2020

Related Concept Videos

Prescription, Nonprescription and Orphan Drugs01:02

Prescription, Nonprescription and Orphan Drugs

Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
Opioid Receptors: Overview01:22

Opioid Receptors: Overview

Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2, D-Pen5]-enkephalin or DPDPE for...
Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents01:17

Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents

Diarrhea, a condition marked by frequent loose or watery bowel movements, can be triggered by multiple factors such as viral or bacterial infections, food intolerances, anxiety, medications, and digestive disorders. Symptoms may include abdominal pain, bloating, nausea, and cramping. Severe or prolonged diarrhea can lead to complications like electrolyte imbalances, malnutrition, and dehydration if left untreated.
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...